Telomir Pharmaceuticals (Telomir Pharmaceuticals) Accounts Payable & Accrued Expense : $0.49 Mil (As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Telomir Pharmaceuticals Accounts Payable & Accrued Expense?

Telomir Pharmaceuticals's quarterly accounts payable & accrued expense declined from Sep. 2023 ($1.80 Mil) to Dec. 2023 ($1.24 Mil) and declined from Dec. 2023 ($1.24 Mil) to Mar. 2024 ($0.49 Mil).

Telomir Pharmaceuticals's annual accounts payable & accrued expense increased from Dec. 2021 ($0.14 Mil) to Dec. 2022 ($0.99 Mil) and increased from Dec. 2022 ($0.99 Mil) to Dec. 2023 ($1.24 Mil).

Telomir Pharmaceuticals Accounts Payable & Accrued Expense Historical Data

The historical data trend for Telomir Pharmaceuticals's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telomir Pharmaceuticals Accounts Payable & Accrued Expense Chart

Telomir Pharmaceuticals Annual Data

Trend

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

0.14

0.99

1.24

Telomir Pharmaceuticals Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial				-	1.55	1.80	1.24	0.49

Telomir Pharmaceuticals Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Telomir Pharmaceuticals (Telomir Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Telomir Pharmaceuticals Inc (NAS:TELO) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Telomir Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells.

Telomir Pharmaceuticals (Telomir Pharmaceuticals) Headlines

From GuruFocus

UPDATE -- Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Canines

By GlobeNewswire • 03-29-2024